Applications published 22 November 2006

Chronotherapeutic compsns and methods of their use
Athpharma 1722758*

Chitosan containing solution
Archimedes Development 1722759*

Delivery of genes encoding short hairpin RNA using receptor-specific nanocontainers
The Regents of the University of California 1722760*

Method of producing microparticles
The School of Pharmacy, University of London 1722761*

Nanocell drug delivery system
Massachusetts Institute of Technology 1722762*

Plaster that reduces skin irritation
Gruenenthal 1722763*

Methods for the relief of pain
Imperial Innovations 1722764*

Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone
The Regents of the University of Michigan 1722765*

Management of ophthalmologic disorders, including macular degeneration
President and Fellows of Harvard College 1722766*

Non-peptidyl agents with PHSP20-like activity, and uses thereof
Prolexys Pharmaceuticals 1722767*

Medicaments for treating Barrett's oesophagus
The Medical Research Council 1722768*

Methods for altering insulin secretion
Merck Patent 1722769*

Use of metformin and orlistat for the treatment or prevention of obesity
Fournier Laboratories Ireland 1722770*

Compsns and methods for preventing or treating an inflammatory response
McGill University 1722771*

Dietary supplementation with stoichiometrically specific potassium magnesium citrate
Mission Pharmacal 1722772*

Pregabalin compsn
Pfizer 1722773*

Use of a compound modifying an interleukin 5, interleukin 6 and/or interleukin 10 secretion for preparing a pharmaceutical treatment for rosacea treatment
Galderma Research & Development 1722774*

Use of beta-lapachone for treating haematologic tumours
Arqule 1722775*

Use of beta-lapachone as a broad spectrum anti-cancer agent
Arqule 1722776*

Use of beta-lapachone for the treatment of pancreatic cancer
Arqule 1722777*

Methods and compsns for the treatment of lipodystrophy
Applied Research Systems 1722778*

Neo-tanshinlactone and analogues as potent and selective anti-breast cancer agents
The University of North Carolina at Chapel Hill 1722779*

A method of preventing or treating glaucoma
Duke University 1722780*

Maleiimide anti-tumour phosphatase inhibitors
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1722781*

Compounds, compsns and methods for inhibiting or treating HIV-1
Cytokine Pharmasciences 1722782*

Ion channel modulators
Wyeth 1722783*

Ion channel modulators
Wyeth 1722784*

Ion channel modulators
Wyeth 1722785*

Therapeutic modulation of PPAR (gamma) activity
Amgen 1722789*

Novel bicyclic compounds as modulators of androgen receptor function and method
Bristol-Myers Squibb 1722790*

Synthesis of epithilones, intermediates thereto, analogues and uses thereof
Sloan Kettering Institute for Cancer Research 1722791*

Selected CGRP-antagonists, method for the production and use thereof as medicaments
Boehringer Ingelheim International 1722792*

Bicyclic modulators of androgen receptor function
Bristol-Myers Squibb 1722793*

Methods and compsns for the treatment of conditions related to gastric acid secretion
Allergan 1722794*

Piperidinyl prostaglandin E analogues
Allergan 1722795*

Tetracyclic lactam derivatives and uses thereof
Inotek Pharmaceutical 1722796*

Isoquinoline derivatives and methods of use thereof
Inotek Pharmaceuticals 1722797*

Pyrimidine compounds as purine receptor antagonist
Vernalis (R&D) 1722798*

Treatment of pulmonary artery hypertension with DHEA, DHEAS, DHEA analogues or DHEA derivatives
Baulieu, Etienne-Emile 1722799*

A medical solution, a method for producing said medical solution and use thereof
Gambro Lundia 1722780*

Use of enhanced water to improve blood sugar management
Wellness Enterprises 1722801*

A medical solution, a method for producing said medical solution and use thereof
Gambro Lundia 1722802*

Extrapallial fluid of molluscs, method of obtaining same, formulation and use thereof
Societe d'Innovation et de Recherche Appliquee 1722803*

Skin treatment method with lactobacillus extract
E-L Management 1722804*

Bioactive compsns from theacea plants and processes for their production and use
Integrated Botanical Technologies 1722805*

Methods for isolation of triptolide compounds from triterygium wilfordii
Pharmagenesis 1722806*

Methods for reducing oxidative damage
Cornell Research Foundation 1722807*

EGF receptor epitode peptides and uses thereof
The Ludwig Institute for Cancer Research 1722808*

A differentiation or regeneration-inducing agent for alveoli
Tohoku Tech Tohoku Technoarch; Kringle Pharma 1722811*

Liquefaction processes
Novozymes North America 1722812*

Use of botulinum toxin for preparing a drug for preventing hair growth
Societe de Conseils de Recherche et d'Applications Scientifiques 1722813*

Infectious bursal disease virus antigenic isolates and vaccines
Wyeth 1722814*

Influenza virus vaccines
Chiron 1722815*

Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances
LTS Lohmann Therapie-Systeme 1722816*

Antineoplastic combinations of CCI-779 and rituximab
Wyeth 1722817*

Photoreactive compound specifically binding to calcium binding proteins
Ben Gurion University of the Negev Research and Development Authority 1722818*

Method for solubilising peptide mixtures
Intercell 1722819*

Long-acting solid formulation comprising triptorelin acetate
Societe de Conseils de Recherches et d'Applications Scientifiques 1722820*

Compsn for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
Hanmi Pharm 1722821*

New complexes
Lipopeptide 1722822*

Pharmaceutical compsn
Antisense Pharma 1722823*

Optical vascular function imaging system and method for detection and diagnosis of cancerous tumours
SRI International 1722824*

Methods for imaging he lymphatic system using dendrimer-based contrast agents
The Government of the United States of America, as represented by the Secretary of Health and Human Services 1722825*

CRF receptor antagonists, their preparations, their pharmaceutical compsns and their uses
SB Pharmco Puerto Rico; Neurocrine Biosciences 1722826*

Radiohalogenated benzamide derivatives and their use in tumour diagnosis and tumour therapy
Schering 1722827*

Wound dressings comprising a protein polymer and a polyfunctional spacer
Advanced Protein Systems 1722833*

Matrix comprising naturally-occurring crosslinked protein backbone
Regentis Biomaterials 1722834*

Hyaluronic acid derivative-based three-dimensional matrix
Fidia Advanced Biopolymers 1722835*

Of at least an antagonist compound of at least one receptor selected from a group comprising beta-adrendergic receptors, A AT1, 5-HT5 and glanain receptor for preparing a pharmaceutical compsn for treating rosacea
Galderma Research & Development 1722855*

Use of 2-methylene-19-nor-20(S)-1-alpha,25-dihydrovitamin D3 for the prophylaxis of bone diseases
Wisconsin Alumni Research Foundation 1722856*

Use of a compound having two gold (1) atoms each covalently bonded to a carbon atom in a covalent link connecting the two gold (1) atoms for the treatment of cancer
The University of Salford; The University of Manchester 1722857*

Ester derivatives of rhein and their therapeutic use
Sosei R&D 1723097*

Method for the functionalisation of conjugated or conjugateable derivatives assisted by a tempo-type electrophoretic mediator
Centre National de la Recherche Scientifique-CNRS 1723098*

Telephthalamide peptidomimetic compounds and methods
Yale University 1723100*

N-substituted benzene sulphonamides
Elan Pharmaceuticals 1723102*

Method for processing beta-sulphatoethylsulphonylaniline-2-sulphonic acid
BASF 1723103*

Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
Eli Lilly 1723105*

Purification of tegaserod maleate
Teva Pharmaceutical Industries 1723106*

Process for manufacture of racemic carvedilol
Cadila Healthcare 1723107*

Biphenyl compounds useful as muscarinic receptor antagonists
Theravance 1723108*

Biphenyl compounds useful as muscarinic receptor antagonists
Theravance 1723109*

Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
Merz Pharma 1723116*

Ion channel modulators
Wyeth 1722117*

Dimeric small molecule potentiators of apoptosis
Board of Regents, the University of Texas System 1723122*

Ion channel modulators
Wyeth 1723123*

Propenoyl hydrazides
Georgia Tech Research Corp 1723124*

Novel 1,2,4-benzotriazine-1,4-dioxides
Aukland Uniservices 1723125*

Novel MCH receptor antagonists
Eli Lilly 1723126*

Analogues exhibiting inhibition of cell proliferation, methods of making, and uses thereof
The Ohio State University Research Foundation 1723127*